|
interleukin-33 signaling pathway
|
PW_0000885 |
|
|
regulation of EGF signaling pathway
|
regulation_of_EGF_signaling_pathway |
|
|
interleukin-1 signaling pathway
|
PW_0000883 |
|
|
altered corticosteroid signaling pathway
|
PW_0000880 |
|
|
hydroxyestrone metabolic pathway
|
hydroxyestrone_metabolic_pathway |
|
|
altered glucocorticoid signaling pathway
|
PW_0000881 |
|
|
positive regulation of growth hormone receptor signaling pathway
|
GO_0060399 |
|
|
NO-cGMP-PKG pathway
|
NO-cGMP-PKG_pathway |
|
|
Stat5 signaling pathway
|
Stat5_signaling_pathway |
|
|
altered cortisol signaling pathway
|
PW_0000879 |
|
|
binding of Mdm2 and p14ARF
|
binding_of_Mdm2_and_p14ARF |
|
|
binding of CDK7 and cyclin H
|
binding_of_CDK7_and_cyclin_H |
|
|
binding of estrogen receptor and p160 coactivator
|
binding_of_estrogen_receptor_and_p160_coactivator |
|
|
deoxyribonucleotide metabolic pathway
|
PW_0000875 |
|
|
erlotinib pharmacokinetics pathway
|
PW_0000873 |
|
|
erlotinib drug pathway
|
PW_0000872 |
|
|
amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
|
amplification_of_signal_from_unattached_kinetochores_via_a_MAD2_inhibitory_signal |
|
|
erlotinib pharmacodynamics pathway
|
PW_0000874 |
|
|
IFNgamma -mediated phosphorylayed STAT1 alpha signaling pathway
|
IFNgamma_-mediated_phosphorylayed_STAT1_alpha_signaling_pathway |
|
|
gefitinib pharmacodynamics pathway
|
PW_0000871 |
|
